AUTOSOMAL DOMINANT OPTIC ATROPHY

Clinical trials for AUTOSOMAL DOMINANT OPTIC ATROPHY explained in plain language.

Never miss a new study

Get alerted when new AUTOSOMAL DOMINANT OPTIC ATROPHY trials appear

Sign up with your email to follow new studies for AUTOSOMAL DOMINANT OPTIC ATROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

First human trial for genetic eye disease treatment begins

Disease control Recruiting now

This early-stage study is testing the safety of a new eye injection called PYC-001 in adults with a specific genetic condition that causes progressive vision loss (OPA1-related optic atrophy). About 21 participants in the UK and Australia will receive different doses and schedule…

Matched conditions: AUTOSOMAL DOMINANT OPTIC ATROPHY

Phase: PHASE1, PHASE2 • Sponsor: PYC Therapeutics • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

AUTOSOMAL DOMINANT OPTIC ATROPHY

Get alerted when new AUTOSOMAL DOMINANT OPTIC ATROPHY trials appear

First human trial for genetic eye disease treatment begins